Tag: psoriatic arthritis

1. Janus kinase (JAK) inhibitor upadacitinib showed non-inferior efficacy in improving psoriatic arthritis compared to standard-of-care adalimumab. 2. High-dose upadacitinib was associated with more frequent adverse events than adalimumab. Evidence Rating Level: 1 (Excellent) Study Rundown: Psoriatic arthritis (PA) is an autoimmune condition primarily affecting the skin and joints. The condition is...
Originally published by Harvard Health. What Is It? Psoriatic arthritis is a chronic (long-lasting) disease in which a person with psoriasis develops the symptoms and signs of arthritis joint pain, stiffness and swelling. Psoriasis is a common, inherited skin condition that causes grayish-white scaling over a pink or dull-red skin rash. Approximately...
1. Brodalumab was found to produce a 20% improvement in various clinical domains for patients with active psoriatic arthritis by week 12 of treatment.  Evidence Rating Level: 1 (Excellent)  Study Rundown: Psoriatic arthritis (PsA) affects approximately up to 30% of patients with a history of psoriasis. In addition to skin manifestations, other...